Literature DB >> 15567898

Peripheral vasculopathy in patients with systemic sclerosis: difference in limited and diffuse subset of disease.

Predrag Ostojić1, Nemanja Damjanov, Slavica Pavlov-Dolijanovic, Goran Radunović.   

Abstract

OBJECTIVE: To examine the difference in clinical signs of peripheral vasculopathy in patients (pts) with limited (lcSSc) and diffuse cutaneus systemic sclerosis (dcSSc). PATIENTS AND METHODS: Ninety one patients with systemic sclerosis (39 with lcSSc and 52 with dcSSc) have been assessed for the presence of clinical signs of vascular injury: Raynaud's phenomenon, severity of capillary damage on capillaroscopy, presence or absence of finger-tip ulcers or pitting scars, presence of telangiectasias and radiographic signs of finger-tip osteolysis. Statistical significance of difference in clinical manifestations of peripheral vasculopathy in pts with lcSSc and dcSSc was assessed using the Mann-Whitney and X2-test.
RESULTS: Duration of Raynaud's phenomenon before manifestation of skin or internal organ damage, was significantly longer (z=-2.54, p=0.004) in patients with lcSSc (5.4 years) than in patients with dcSSc (1.9 years). Using the technique of nailfold capillaroscopy, we found normal capillaries or non-specific capillary change in 10.2% pts with lcSSc and only in 2.0% pts with dcSSc. Enlarged capillaries without significant loss of capillaries were found in 38.5% pts with lcSSc, and 11.5% pts with dcSSc (p=0.05). But severe capillary damage, with significant loss of capillaries, was noticed more frequently in pts with dcSSc (dcSSc/lcSSc: 86.5%/51.3%, p=0.002). Pitting scars or digital ulcers were found in 46.2% pts with lcSSc and 67.3% pts with dcSSc (p=0.04). We did not notice significant difference in frequency of finger-tip osteolysis (lcSSc/dcSSc: 23.1%/21.2%, p>0.05) and telangiectasias (lcSSc/dcSSc: 46.2%/53.8%, p>0.05).
CONCLUSION: Severe capillary damage and digital ulcers are more common in patients with diffuse cutaneus systemic sclerosis, but finger-tip osteolysis and telangiectasias are equally frequent in both form of disease.

Entities:  

Mesh:

Year:  2004        PMID: 15567898

Source DB:  PubMed          Journal:  Clin Hemorheol Microcirc        ISSN: 1386-0291            Impact factor:   2.375


  5 in total

1.  Plasma endogenous enkephalin levels in early systemic sclerosis: clinical and laboratory associations.

Authors:  Terry A McNearney; K A Sluka; C Ahn; J D Reveille; Michael Fischbach; Maureen D Mayes
Journal:  Clin Exp Rheumatol       Date:  2010-06-10       Impact factor: 4.473

2.  Arterial hypertension treated with angiotensin converting enzyme inhibitors and glucocorticoids are independent risk factors associated with decreased glomerular filtration rate in systemic sclerosis.

Authors:  Predrag Ostojic; Natasa Stojanovski
Journal:  Rheumatol Int       Date:  2016-12-22       Impact factor: 2.631

3.  [Digital ulcers in systemic scleroderma].

Authors:  D Belz; N Hunzelmann; P Moinzadeh
Journal:  Hautarzt       Date:  2014-11       Impact factor: 0.751

4.  A score of risk factors associated with ischemic digital ulcers in patients affected by systemic sclerosis treated with iloprost.

Authors:  Paola Caramaschi; Nicola Martinelli; Alessandro Volpe; Sara Pieropan; Ilaria Tinazzi; Giuseppe Patuzzo; Helal Mahamid; Lisa Maria Bambara; Domenico Biasi
Journal:  Clin Rheumatol       Date:  2009-03-20       Impact factor: 2.980

Review 5.  Predicting the Progression of Very Early Systemic Sclerosis: Current Insights.

Authors:  Chiara Bellocchi; Augustine Chung; Elizabeth R Volkmann
Journal:  Open Access Rheumatol       Date:  2022-09-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.